Authors:
,
,
, and
Arthit Wongsaensook
Arthit Wongsaensook
Department of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand
Srinagarind Hospital, Mittraparp Road, Muang, Khon Kaen, 40002, Thailand
Search for other papers by Arthit Wongsaensook in
Current site
Google Scholar
PubMed
Srinagarind Hospital, Mittraparp Road, Muang, Khon Kaen, 40002, Thailand
Search for other papers by Arthit Wongsaensook in
Current site
Google Scholar
PubMed
Wattana Sukeepaisarnjaroen
Wattana Sukeepaisarnjaroen
Department of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand
Search for other papers by Wattana Sukeepaisarnjaroen in
Current site
Google Scholar
PubMed
Search for other papers by Wattana Sukeepaisarnjaroen in
Current site
Google Scholar
PubMed
Wisut Sukeepaisarnjaroen
Wisut Sukeepaisarnjaroen
Department of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand
Search for other papers by Wisut Sukeepaisarnjaroen in
Current site
Google Scholar
PubMed
Search for other papers by Wisut Sukeepaisarnjaroen in
Current site
Google Scholar
PubMed
Churairat Kularbkaew
Churairat Kularbkaew
Department of Pathology, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand
Search for other papers by Churairat Kularbkaew in
Current site
Google Scholar
PubMed
Search for other papers by Churairat Kularbkaew in
Current site
Google Scholar
PubMed
Abstract
Aim: To evaluate risks and benefits of percutaneous liver biopsies in Srinagarind Hospital, Khon Kaen, Thailand. Methods: We retrospectively reviewed all patients who had performed liver biopsies between January 2005 and September 2009 from the data of the Srinagarind Memorial Building, Khon Kaen University, Thailand. Results: A total of 1038 liver biopsies were reviewed. The 927 liver biopsies performed were blind (89.3%), 110 were ultrasound guided (10.6%) and one was both (0.1%). The essential biopsies were conducted in cases of chronic hepatitis B or C (68.9%), chronic hepatitis (22.9%) and liver mass (5%). The liver biopsies established definite diagnosis 99.5% of the time. The most common complication of liver biopsies was pain (4.8%). There were no reported cases of biopsy-related mortality. Conclusion: Liver biopsies performed by trained physicians are safe, rarely have complications, and are highly useful. The fibrotic staging and abnormal liver function tests are common indications. Nonalcoholic steatohepatitis is the common finding for chronic hepatitis.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. A. Grant J. Neuberger 1999 Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology Gut 45 Suppl4 IV1 IV11.
-
2. R. Valori E. Elias 1989 How to perform a percutaneous liver biopsy Bri J Hos Med 42 408 409.
-
3. I.T. Gilmore A. Burroughs I.M. Murray-Lyon R. Williams D. Jenkins A. Hopkins 1995 Indication, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London Gut 36 437 441.
-
4. S. Sherlock J. Dooley 2002 Chapter 3: Biopsy of the Liver S. Sherlock J. Dooley Diseases of the Liver and Biliary System 11th ed. Blackwell Science Ltd Oxford, UK 37 44.
-
5. D.J. Van Leeuwen L. Wilson D.R. Crowe 1995 Liver biopsy in the mid-1990s: questions and answers Semin Liver Dis 15 340 359.
-
6. F. Piccinino E. Sagnelli G. Pasquale G. Giusti 1986 Complications following percutaneous liver biopsy: a multicentre retrospective study on 68,276 biopsies J Hepatol 2 165 173.
-
7. G. Garcia-Tsao J.L. Boyer 1993 Outpatient liver biopsy: how safe is it? Ann Intern Med 118 150 153.
-
8. C.H. Janes K.D. Lindor 1993 Outcome of patients hospitalized for complications after outpatient liver biopsy Ann Intern Med 118 96 98.
-
9. A.S.F. Lok P.C. Wu C.L. Lai E.K.Y. Leung 1988 Long-term follow-up in a randomised controlled trial of recombinant a2-interferon in Chinese patients with chronic hepatitis B infection Lancet 2 298 302.
-
10. D.K.H. Wong A.M. Cheung K. O'Rourke C.D. Naylor A.S. Detsky J. Heathcote 1993 Effect of alfa-interferon treatment in patients with hepatitis B e antigen-positive hepatitis B: meta-analysis Ann Intern Med 119 312 323.
-
11. H.L.Y. Chan N.W.Y. Leung M. Hussain M.L. Wong A.S.F. Lok 2000 Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong Hepatology 31 763 768.
-
12. G.L. Davis J.B. Wong J.G. McHutchison et al.2003 Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C Hepatology 38 645 652.
-
13. S. Sherlock 1989 Diseases of the Liver and Biliary System: Needle Biopsy of the Liver 8th ed. Blackwell Scientific Publications Boston — Melbourne 36 48.
-
14. J.E. Hegarty R. Williams 1988 Liver biopsy: techniques, clinical applications, and complications Br Med J (Clin Res Ed) 288 1254 1256.
-
15. P.A. McVay P.T.C.Y. Toy 1990 Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities Am J Clin Pathol 94 747 753.
-
16. P. Sharma G.B. McDonald M. Banaji 1982 The risk of bleeding after percutaneous liver biopsy: relation to platelet count J Clin Gastroenterol 4 451 453.
-
17. S.G. West 1997 Methotrexate hepatotoxicity Rheum Dis Clin N Am 23 883 915.
-
18. Q.E. Whiting-O'Keefe K.H. Fye K.D. Sack 1991 Methotrexate and histologic hepatic abnormalities: a meta-analysis Am J Med 90 711 716.
-
19. J.M. Kremer G.S. Alarcon R.W. Lightfoot et al.1994 Methotrexate for rheumatoid arthritis suggested guidelines for monitoring liver toxicity Arthritis Rheum 27 316 328.
-
20. H.J. Roenigk R. Auerbach H.I. Maibach G.D. Weinstein 1988 Methotrexate in psoriasis: revised guidelines J Am Acad Derm 19 145 156.
-
21. National Institute for Health and Clinical Excellence: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. Technology Appraisal 2006 (106). Available from: URL: http://www.nice.org.uk/TA106.
-
22. National Institute for Health and Clinical Excellence: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C. Technology Appraisal 2004 (75). Available from: URL: http://www.nice.org.uk/TA75.
-
23. U.L. Mathiesen L.E. Franzen A. Fryden U. Foberg G. Bodemar 1999 The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients Scand J Gastroenterol 34 85 91.
-
24. M.M. Skelly P.D. James S.D. Ryder 2001 Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology J Hepatol 35 195 199.
-
25. S. Daniel T. Ben-Menachem G. Vasudevan C.K. Ma M. Blumenkehl 1999 Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients Am J Gastroenterol 94 3010 3014.
-
26. L. Bianchi 2001 Liver biopsy in elevated liver functions tests? An old question revisited J Hepatol 35 290 329.
-
27. G. Bedogni L. Miglioli F. Masutti C. Tiribelli G. Marchesini S. Bellentani 2005 Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study Hepatology 42 44 52.
-
28. G. Marchesini M. Brizi G. Bianchi et al.2001 Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 1844 1850.
-
29. S.M. Grundy 2005 Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute Arterioscler Thromb Vasc Biol 25 2243 2244.
-
30. S.M. Grundy J.I. Cleeman S.R. Daniels et al.2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2735 2752.
-
31. D. Einhorn G.M. Reaven R.H. Cobin et al.2003 American College of Endocrinology position statement on the insulin resistance syndrome Endocr Pract 9 237 252.
-
32. A. Fotiadu V. Kotoula E. Sinakos et al.2010 Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease Pathol Int 60 87 92.
-
33. S.H. Caldwell A.I. Hylton 2005 The clinical outcome of NAFLD including cryptogenic cirrhosis G.C. Farrell J. George P. de la M. Hall A.J. McCullough Fatty Liver Disease: NASH and Related Disorders Blackwell Publishing Ltd. Oxford, UK 168 180.
-
34. P. Muratori A. Granito G. Pappas et al.2009 The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome Am J Gastroenterol 104 1420 1425.
-
35. K.G. Ishak H.J. Zimmerman M.B. Ray 1991 Alcoholic liver disease: pathologic, pathogenetic and clinical aspects Alcohol Clin Exp Res 15 45 66.
-
36. G. Garcia-Tsao J.L. Boyer 1993 Outpatient liver biopsy: how safe is it? Ann Intern Med 118 150 153.
-
37. C.H. Janes K.D. Lindor 1993 Outcome of patients hospitalized for complications after outpatient liver biopsy Ann Intern Med 118 96 98.
-
38. J. Perrault D.B. McGill B.J. Ott et al.1978 Liver biopsy: complications in 1000 inpatients and outpatients Gastroenterology 74 103 106.
-
39. G. Vautier B. Scott D. Jenkins 1994 Liver biopsy: blind or guided? BMJ 309 1455 1456.
-
40. E. Caturelli A. Giacobbe D. Facciorusso M. Bisceglia M.R. Villani D.A. Siena S. Fusilli M.M. Squillante A. Andriulli 1996 Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site Am J Gastroenterol 91 1318 1321.
-
41. F. Piccinino E. Sagnelli G. Pasquale G. Giusti 1986 Complications following percutaneous liver biopsy: a multicentre retrospective study on 68,276 biopsies J Hepatol 2 165 173.
| 2019 | |
|---|---|
| Scimago H-index |
11 |
| Scimago Journal Rank |
0,220 |
| Scimago Quartile Score |
Medicine (miscellaneous) Q3 |
| Scopus Cite Score |
155/133=1,2 |
| Scopus Cite Score Rank |
General Medicine 199/529 (Q2) |
| Scopus SNIP |
0,343 |
| Scopus Cites |
206 |
| Scopus Documents |
23 |
| Interventional Medicine and Applied Science | |
|---|---|
| Language | English |
| Size | |
| Year of Foundation |
2009 |
| Publication Programme |
changed title |
| Volumes per Year |
|
| Issues per Year |
|
| Founder | Akadémiai Kiadó |
| Founder's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 2061-1617 (Print) |
| ISSN | 2061-5094 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Mar 2024 | 11 | 0 | 0 |
| Apr 2024 | 20 | 0 | 0 |
| May 2024 | 2 | 0 | 0 |
| Jun 2024 | 7 | 0 | 0 |
| Jul 2024 | 31 | 0 | 0 |
| Aug 2024 | 15 | 0 | 0 |
| Sep 2024 | 9 | 0 | 0 |
Author:
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Powered by PubFactory